Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) of Hansa Biopharma AB, effective July 14. Philipson will report to CEO Renée Aguiar-Lucander, who joined the company earlier this year, and be a member of the Executive Committee. “We are very pleased to welcome Dr Philipson to the executive management team as CMO. He brings invaluable experience in the area of drug development, from first-in-human to Phase 3, and post-approval studies; with expertise across rare disea...